Trial Profile
Cost effectiveness of rivaroxaban and warfarin for the prevention of stroke in patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2012
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Stroke; Thromboembolism
- Focus Therapeutic Use
- Acronyms ROCKET-AF
- 05 Apr 2012 New trial record
- 27 Mar 2012 Results presented at the 61st Annual Scientific Session of the American College of Cardiology.